• January 4, 2024

New York — Suabix™ is proud to announce its selection to be part of the prestigious 2024 cohort of life science startups of the Westchester County Biosciences Accelerator (WCBA).  The WCBA program, renowned for its commitment to fostering innovation and supporting emerging biosciences ventures, has recognized Suabix as one of twelve ventures to participate in its highly anticipated 6.5-month program. As part of this initiative, Suabix will receive invaluable business education, gain access to an extensive professional network, and receive guidance in developing a fundable business plan.

Suabix™ is poised to revolutionize the healthcare industry by empowering MedTech product developers with crucial guidance and capabilities to develop safe and user-friendly healthcare products. By integrating the Successful Human Factors (SHF) 2.0 framework with cutting-edge AI technologies, Suabix ensures that human factors in healthcare are effectively addressed, elevating patient safety to the forefront.

The selection process for the 2024 WCBA cohort was rigorous, with expert scientists, active investors, and seasoned business strategists meticulously assessing ventures based on the strength of their teams, the uniqueness of their insights, and their potential to drive innovation in the life sciences industry.

“We are incredibly honored to have been chosen as part of the 2024 WCBA cohort,” stated Dr. Rojas, the visionary entrepreneur behind Suabix™. “It underscores the critical role that human factors play in healthcare and affirms the need for innovative solutions like Suabix. We are thrilled to join a vibrant community of entrepreneurs, investors, and mentors who are leading advancements in the biosciences field.”

The WCBA program is dedicated to nurturing the growth and diversification of the local ecosystem in Westchester County, with an unwavering focus on enhancing human health. The program boasts a record of success, with past alumni achieving significant milestones such as generating impressive sales, receiving distinguished awards, and securing substantial funding.

For more information about Suabix and its revolutionary AI-driven platform, please visit www.suabix.com.

For media inquiries and further information, please contact:

Suabix Media Relations
+1 (845) 237-2479

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!